What is the Return on Assets (ROA) of Jafron Biomedical Co this year?
The Return on Assets (ROA) of Jafron Biomedical Co is 0.08 undefined this year.
Jafron Biomedical Co ROA 2024
Jafron Biomedical Co ROA
0.08
Ticker
300529.SZ
ISIN
CNE100002995
In 2024, Jafron Biomedical Co's return on assets (ROA) was 0.08, a -52.08% increase from the 0.16 ROA in the previous year.
Jafron Biomedical Co Aktienanalyse
What does Jafron Biomedical Co do?
Jafron Biomedical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Jafron Biomedical Co's Return on Assets (ROA)
Jafron Biomedical Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Jafron Biomedical Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Jafron Biomedical Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Jafron Biomedical Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Jafron Biomedical Co stock
What was the ROA of Jafron Biomedical Co compared to the previous year?
The ROA of Jafron Biomedical Co has increased by -52.08% compared to the previous year.
What consequences do high ROA have for investors of Jafron Biomedical Co?
A high ROA is advantageous for investors of Jafron Biomedical Co, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Jafron Biomedical Co?
A low ROA can be unfavorable for investors of Jafron Biomedical Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Jafron Biomedical Co affect the company?
An increase in ROA of Jafron Biomedical Co can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Jafron Biomedical Co impact the company?
A reduction in the ROA of Jafron Biomedical Co can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Jafron Biomedical Co?
Some factors that can influence the ROA of Jafron Biomedical Co include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Jafron Biomedical Co important for investors?
The ROA of Jafron Biomedical Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Jafron Biomedical Co take to improve ROA?
To improve ROA, Jafron Biomedical Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Jafron Biomedical Co pay?
Over the past 12 months, Jafron Biomedical Co paid a dividend of 0.67 CNY . This corresponds to a dividend yield of about 2.24 %. For the coming 12 months, Jafron Biomedical Co is expected to pay a dividend of 0.73 CNY.
What is the dividend yield of Jafron Biomedical Co?
The current dividend yield of Jafron Biomedical Co is 2.24 %.
When does Jafron Biomedical Co pay dividends?
Jafron Biomedical Co pays a quarterly dividend. This is distributed in the months of June, July, June, June.
How secure is the dividend of Jafron Biomedical Co?
Jafron Biomedical Co paid dividends every year for the past 10 years.
What is the dividend of Jafron Biomedical Co?
For the upcoming 12 months, dividends amounting to 0.73 CNY are expected. This corresponds to a dividend yield of 2.43 %.
In which sector is Jafron Biomedical Co located?
Jafron Biomedical Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Jafron Biomedical Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Jafron Biomedical Co from 5/31/2024 amounting to 0.4 CNY, you needed to have the stock in your portfolio before the ex-date on 5/31/2024.
When did Jafron Biomedical Co pay the last dividend?
The last dividend was paid out on 5/31/2024.
What was the dividend of Jafron Biomedical Co in the year 2023?
In the year 2023, Jafron Biomedical Co distributed 0.9 CNY as dividends.
In which currency does Jafron Biomedical Co pay out the dividend?
The dividends of Jafron Biomedical Co are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Jafron Biomedical Co
Our stock analysis for Jafron Biomedical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jafron Biomedical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Jafron Biomedical Co Revenue
- Jafron Biomedical Co Net Income
- Jafron Biomedical Co P/E
- Jafron Biomedical Co P/S
- Jafron Biomedical Co EBIT
- Jafron Biomedical Co Dividend
- Jafron Biomedical Co Stocks
- Jafron Biomedical Co Market capitalization
- Jafron Biomedical Co Debt
- Jafron Biomedical Co Liabilities
- Jafron Biomedical Co Equity
- Jafron Biomedical Co AAQS
- Jafron Biomedical Co Employees
- Jafron Biomedical Co ROE
- Jafron Biomedical Co ROA
- Jafron Biomedical Co ROCE